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A patient with a severe remote-effect polyneuropathy and other 
paraneoplastic features of osteosclerotic myeloma improved dramat- 
ically with melphalan and prednisone treatment. Serial electrodiag- 
nostic studies provided an objective means of following the response 
to therapy and documented the improvement. We believe this repre- 
sents the first reported patient with multifocal osteosclerotic myeloma 
and a myelomatous polyneuropathy responding to melphalan and 
prednisone. 
MUSCLE & NERVE 7:137-141 1984 
PERIPHERAL NEUROPATHY IN OSTEOSCLEROTIC 
MYELOMA: CLINICAL AND ELECTRODIAGNOSTIC 
IMPROVEMENT WITH CHEMOTHERAPY 
P. D. DONOFRIO, MD, J. W. ALBERS, MD, PhD, 
H. S. GREENBERG, MD, and 8. S. MITCHELL, MD 
Peripheral neuropathy is detected clinically in 
only 3%-5% of patients with multiple 
However, approximately half the patients with the 
osteosclerotic form of plasma cell dyscrasia mani- 
fest a severe polyneuropathy, the neuropathy of- 
ten preceding the detection of osteosclerotic le- 
sions by months to  year^.^.'^" Improvement in 
myelomatous neuropathy has been reported in pa- 
tients with solitary lesions following radiation ther- 
a~y,~*’-’O but rarely in patients with multifocal le- 
sions after chemotherapy.5*’ Electrodiagnostic 
documentation of the clinical improvement has 
been rovided in only two patients with a solitary 
lesionisg but not in those few patients with mul- 
tifocal osteosclerotic lesions receiving chemother- 
apy. We report a patient with a severe demyelinat- 
ing sensorimotor polyneuropathy and multifocal 
osteosclerotic bone lesions in whom melphalan and 
prednisone therapy resulted in considerable clini- 
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cal and electrodiagnostic improvement in the 
peripheral neuropathy, and associated remote- 
effects. 
CASE REPORT 
A forty-two-year-old woman presented with a 3- 
year history of progressive weakness, gait un- 
steadiness, and painful extremity dysesthesia. This 
was accompanied by hirsutism, frequent diarrhea, 
and a 50-pound weight loss. A prior evaluation 
disclosed the following: electromyographic evi- 
dence of a polyneuropathy ; pelvic roentgeno- 
grams demonstrating osteosclerotic lesions in the 
iliac crest, lumbar spine, and sacrum; and bone 
scan evidence of increased activity in the right 
sacrum. 
On physical examination, the patient was a 
thin, chronically ill appearing woman who had 
finger clubbing and increased facial and extremity 
hair. On assuming the upright position, orthostatic 
distal cyanosis developed in her upper and lower 
extremities. Moderate hepatomegaly , hammer 
toes, and high arches were present. There was 
marked wasting of the frontalis, temporalis, and 
sternocleidomastoid muscles, with accompanying 
muscle atrophy and weakness involving the ex- 
tremities distally more than proximally. She had 
slow alternating movements and a mild distal 
tremor. Her gait was wide-based and steppage in 
quality. Muscle stretch reflexes were absent. A dis- 
tal gradient loss to nociceptive, proprioceptive, and 
vibratory modalities was present. 
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FIGURE 1. Multiple scattered sclerotic bone lesions within the right humerus and clavicle. 
Laboratory studies revealed normal routine 
hematologic and blood chemistry parameters ex- 
cept for elevation of hemoglobin and hematocrit. 
Roentgenographic bone survey revealed multiple 
osteosclerotic lesions in the ribs, vertebral bodies, 
clavicles, humeri, pelvic bones, and proximal 
femurs ranging from several millimeters to centi- 
meters in size (Fig. 1). Bone scan was normal. Per- 
cutaneous bone marrow and liver biopsies were 
normal. A rectal biopsy showed no evidence of 
amyloid deposition, while a cervical lymph node 
biopsy was negative for lymphoma. Multiple pro- 
tein electrophoretic evaluations of serum and 
urine were unremarkable. One of numerous 
serum immunoelectrophoreses disclosed an ele- 
vated IgA of 420 mg/dl (normal 24-386), yet a 
monoclonal protein was never isolated. Cerebro- 
spinal fluid analysis was normal. Fluoroscopy- 
guided needle biopsy of a right humeral osteo- 
sclerotic lesion disclosed an overall increased 
number of plasma cells within the bone marrow, 
with several focal areas of dense plasma cell 
infiltration. 
A monthly chemotherapeutic regimen consist- 
ing of melphalan (12 mg for 4 days) and predni- 
sone (140 mg for 4 days) resulted in complete reso- 
lution of pain, hirsutism, and orthostatic cyanosis 
after 22 months of treatment. Repeat neurologic 
examination showed normalization of nocicep- 
tive, temperative, and proprioceptive modalities, 
as well as return of physiologic muscle stretch 
reflexes. On muscle strength testing, improvement 
of 1-2 grades in the upper extremities and 0.5-2.5 
grades in the lower extremities (MRC scale) was 
observed; those changes more impressive distally 
than proximally. Partial clearing of the osteo- 
sclerotic lesions in the right humeral head and 
clavicle after chemotherapy provided a roent- 
genographic counterpart to the clinical ameliora- 
tion (Fig. 2). Posttreatment serum immunoelec- 
trophoresis revealed an IgA of 23 1. The patient is 
now fully ambulatory and has returned to fulltime 
employment. 
Electrodlagnostic Evaluation. Pre- and posttreat- 
ment serial electrodiagnostic testing demonstrated 
significant improvement in motor and sensory 
evoked amplitudes, distal latencies, and conduc- 
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FIGURE 2. Marked resolution of the sclerotic lesions in the right humerus after chemotherapy. 
tion velocities (Table l),  paralleling the clinical re- 
sponse. These results are represented on a sepa- 
rate graph (Fig. 3), relating averaged recordable 
electrodiagnostic responses to the course of the 
disease expressed as a percentage of the lower limit 
of normal for age-matched control subjects. No 
improvement was recorded on serial needle exami- 
nations for those parameters reflecting distal ax- 
onal degeneration and reinnervation. 
DISCUSSION 
Approximately 40%-50% of cases of osteosclerotic 
myeloma reported by Iwashita et al.? as well as 
Driedger and Pruzanski: were associated with 
polyneuropathy. When contrasted to the clinical 
presentation of typical multiple myeloma, these 
patients usually present at a younger age, are not 
systemically ill, and manifest a lower percentage of 
abnormalities in serum and urine immunoglobulin 
analysis, serum calcium, renal function, hemato- 
logic parameters, and sedimentation rates. Lymph- 
adenopathy, splenomegaly, and hepatomegaly 
may be present.439 In addition, these patients may 
have hyperpigmentation, excessive perspiration, 
peripheral edema, papilledema, digital clubbing, 
hypertrichosis, and a myriad of associated endo- 
crine abnormalities, including gynecomastia, hy- 
pothyroidism, diabetes, impotence, amenorrhea, 
hirsutism, and elevated serum estrogen or reduced 
testosterone levels. 1 * 6 9 7 * 9  
Laboratory abnormalities include radiologic 
evidence of solitary or multiple oste~sclerosis.~’” 
Bone marrow aspiration or biopsy may be normal, 
or have a modest increase (5 5 % )  in normal- 
appearing plasma cells, while fluoroscopically di- 
rected needle biopsy or open surgical biopsy of a 
suspected bone lesion usually reveals bone marrow 
plasma~ytosis.~*~ Other abnormalities are anemia, 
polycythemia, leukocytosis, thrombocytosis, throm- 
bocytopenia, and elevated CSF protein. Results 
of serum protein electrophoresis and immu- 
noelectrophoresis are quite variable. An M-pro- 
tein may not be detected in the serum or urine 
in approximately 25% of patients with osteo- 
sclerotic myeloma, yet levels as elevated as 7.4 g/dl 
have been 
Electrodiagnostic studies reveal characteristic 
abnormalities: low amplitude or absent motor and 
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Table 1. Electrodiagnostic results. 
Motor conduction studies 
Date 5180 10180 9/81 1 1 I81 8181 Normal range 
Amplitude (mV) 
Ulnar 3 2 5 5 5.5 (6-16) 
Median 4 3 - 8 7 (4-1 8) 
Peroneal NR NR NR NR NR (2-1 2) 
Ulnar 26 24 35 38 39 (49-71) 
Median 25 25 - 34 38 (49-71 ) 
Ulnar 5.6 5.2 3.4 3.7 3.5 (1.8-3.5) 
Conduction velocity (mlsec) 
Distal latency (msec) 
Median 6.5 5.4 - 4.5 3.8 (2.4-4.4) 
Sensory conduction studies 
Amplitude (pV) 
Ulnar 10 12 12 22 30 ('1 5) 
Median 8 10 - 28 25 ('20) 
Sural NR 1 NR 2 2 (6-47) 
Ulnar 34 36 45 51 54 (53-73) 
Median - 30 - 45 47 (53-73) 
Ulnar 5.4 5.6 3.8 3.5 3.6 (2.4-3.5) 
Median 5.5 5.4 - 3.6 3.6 (2.5-3.7) 
Conduction velocity (msec) 
Distal latency (msec) 
Sural NR 7.2 NR 5.6 4.8 (3.2-4.2) 
Treatment initiation 9/80 
NR = No response 
(-) = Not done. 
sensory evoked responses, prolonged distal laten- 
cies, progressive dispersion of motor evoked re- 
sponses with proximal stimulation, and moderate 
to marked slowing of conduction velocity. Distal 
greater than proximal fibrillation potentials and 
reduced voluntary motor unit potentials with asso- 
ciated changes of chronic denervation are re- 
corded on needle e~amination,~, '  Nerve biopsy 
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FIGURE 3. Mean sensory and motor evoked response am- 
plitude, conduction velocity, and distal conduction velocity 
of recordable nerves expressed as percentage of the lower 
limit of normal, before and after treatment. 
specimens demonstrate combined axonal degener- 
ation and demyelination with remyelination. 1s8*y*'3 
Documented improvement in the peripheral 
neuropathy of osteosclerotic myeloma after radia- 
tion therapy has been reported in numerous cases 
of solitary osteosclerotic myeloma, but not in cases 
with multifocal l e s i ~ n s . ~ ~ ' - ' ~  Reitan et al.' and 
Driedger and Pruzanski5 described patients with 
multifocal osteosclerotic myeloma whose neuropa- 
thy improved after treatment using prednisone 
andor  cyclophosphamide, although posttreatment 
electrodiagnostic studies were not described. None 
of the seven patients with multifocal osteosclerotic 
myeloma reported by Kelly et al.'*' substantially 
improved or maintained improvement after che- 
motherapy. Posttreatment electrodiagnostic stud- 
ies demonstrated doubling of the evoked am- 
plitude and nerve conduction velocities in two 
patients with solitary osteosclerotic lesions treated 
with radiation therapy.',' In our patient, the 
marked improvement in nerve conduction veloci- 
ties and evoked amplitudes reflects repair of the 
most readily reversible component of the neuropa- 
thy, i.e., demyelination. 
We believe this represents the first reported 
case of myelomatous polyneuropathy associated 
with multifocal osteosclerotic myeloma unequivo- 
cally responding to melphalan and prednisone, 
and having serial electrodiagnostic documentation 
of the clinical improvement. 
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